HK Stock Midday Review: Hang Seng Index Up 0.67%, AI Pharma and Tech Stocks Lead Gains
nashnova research
The Hang Seng hit 24,768 at midday, up 0.67%, while the Hang Seng Tech index surged 1.74%; money piled heavily into AI-driven pharma, optical communications and computing hardware, making tech-growth the clear driver of the morning rally.
Why did AI pharma stocks explode across the board?
The trigger: ten government agencies jointly released a "15th Five-Year" plan for the pharma industry, and brokerages read it as a signal that the sector is entering an AI-driven new phase.
XtalPi (02228) announced a Stanford collaboration on AI drug discovery and jumped over 12%; MoleculeAI (07666) rose over 12%; Insilico Medicine (03696) gained over 9%.
This means → the market treated the plan as official endorsement — AI + pharma is no longer just a concept; it now has top-level policy backing.
Impact Therapeutics (07630) surged over 12%, recently added to Stock Connect with insider buying; its core drug Senapali is accelerating sales — a rare policy + capital + fundamentals triple catalyst.
What is driving the optical-comms and computing-hardware rally?
Lightelligence (01879) jumped over 17% after Goldman Sachs published a report — having visited several optical firms — expressing a positive outlook on optical supply-chain demand.
This means → Goldman's field-research conclusion acts as a short-term confidence anchor for the optical sector — sell-side endorsement plus industry upturn draws capital fast.
Iluvatar CoreX (09903) rose over 13%, riding the twin themes of rising AI capex and domestic computing self-reliance (Beijing's push to replace foreign chips).
Junzhi Group (01300) gained over 10% after acquiring Qinghai Zhongli Fiber, a deal the market sees as opening up incremental AI-linked fiber-optic revenue.
Any standouts among blue chips and robotics?
Lenovo (00992) rallied over 7%, leading blue chips. CFO William Amelio said Lenovo is "severely undervalued" and targets Dell-level net margins.
In plain terms = management is publicly saying "we're too cheap," handing the market a reason to re-rate the stock.
MINIMAX-W (00100) surged 13% after several products were added to Singtel's AI Pass subscription bundle, widening sharply from the 3.92% early-session gain.
Yunji (02670) soared over 18% as its multi-modal robot UP entered several top-tier hospitals — robots moving from showrooms into real medical settings.
Who is bucking the trend and falling?
Gold miners under pressure: Shandong Gold (01787) fell over 2% and Zhaojin Mining (01818) dropped 3%, weighed down by Fed rate-hike expectations capping the gold price.
Health 160 (02656) plunged over 10% to a fresh all-time low, now down more than 95% from its March peak.
This reflects the overhang from a major shareholder's lock-up expiry — once the restriction lifted, market confidence collapsed outright.
What should we watch this afternoon?
Morning turnover hit HK$107 billion, with money heavily concentrated in AI pharma, optical comms and computing power.
This means → the directional bet is clear, but staying power is unproven — whether afternoon volume holds up is the key test for how far this rally can run.
In plain terms = the morning session was lively, but the real exam is this afternoon: if turnover fades, today's gains may turn out to be a one-day event.
市场有风险，内容仅供研究参考，不构成投资建议。